Abbott

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Abbott and other ETFs, options, and stocks.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

CEO

Robert B. Ford

CEORobert B. Ford

Employees

115,000

Employees115,000

Headquarters

Abbott Park, Illinois

HeadquartersAbbott Park, Illinois

Founded

1888

Founded1888

Employees

115,000

Employees115,000

ABT Key Statistics

Market cap

181.20B

Market cap181.20B

Price-Earnings ratio

31.68

Price-Earnings ratio31.68

Dividend yield

1.88%

Dividend yield1.88%

Average volume

5.06M

Average volume5.06M

High today

$104.50

High today$104.50

Low today

$102.85

Low today$102.85

Open price

$103.46

Open price$103.46

Volume

5.48M

Volume5.48M

52 Week high

$118.23

52 Week high$118.23

52 Week low

$93.25

52 Week low$93.25

ABT News

Yahoo Finance 3d

Abbott Gains But Lags Market: What You Should Know - Yahoo Finance

Abbott (ABT) closed the most recent trading day at $102.82, moving +0.8% from the previous trading session. This change lagged the S&P 500's 0.99% gain on the d...

Reuters 4d

Abbott accuses one of its former scientists of trade-secrets theft in ... - Reuters

Companies Companies Law Firms Abbott Laboratories Follow May 31 (Reuters) - Healthcare company Abbott Laboratories (ABT.N) on Tuesday sued one o...

Benzinga 6d

Blood Glucose Monitoring Devices Market to grow by USD 7,488.81 million during 2023-2027; The rising glob - Benzinga

NEW YORK, May 29, 2023 /PRNewswire/ -- The blood glucose monitoring devices market is set to grow by USD 7,488.81 mn from 2023 to 2027 progressing at a CAGR of...

Analyst ratings

69%

of 26 ratings

Buy

69.2%

Hold

26.9%

Sell

3.8%

ABT Earnings

$0.00

$0.58

$1.15

$1.73

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Q1 FY23

Q2 FY23

Estimated

$1.05 per share

Estimated$1.05 per share

Actual

Expected Jul 19, Pre-Market

ActualExpected Jul 19, Pre-Market